Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04430634 · ClinicalTrials.gov registry record · NA
A Study to Evaluate Nicotine Uptake and Biomarkers in Smokers Using mybluTM Electronic Cigarettes
A NA study, sponsored by Fontem US.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT04430634 is a NA study that has completed, run by Fontem US. The registered enrollment target is 40 participants.
The verdict
NCT04430634, a NA study, has completed, sponsored by Fontem US.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study evaluates the overall performance of the currently-marketed MybluTM e-cigarette device and pods, as assessed by nicotine uptake, exposure to smoke constituents, safety and consumer satisfaction, over 8 days. The study is designed as an open-label, randomized study in adult smokers. Subjects are invited to participate to a second part of the study, for 5 additional days, to compare the use of MybluTM to the use of subject's usual brand combustible cigarettes.
Interventions
- OTHER Myblu variant A
- OTHER Myblu variant B
- OTHER Myblu variant C
- OTHER Myblu variant D
- OTHER Myblu variant E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2020-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04430634
The ClinicalTrials.gov registry entry for NCT04430634 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fontem US, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Myblu variant A is the first listed.
NCT04430634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04430634 about?
NCT04430634 is a clinical study titled "A Study to Evaluate Nicotine Uptake and Biomarkers in Smokers Using mybluTM Electronic Cigarettes". This study evaluates the overall performance of the currently-marketed MybluTM e-cigarette device and pods, as assessed by nicotine uptake, exposure to smoke constituents, safety and consumer satisfaction, over 8 days. The study is designed as an open-label, randomized study in adult smokers. Subje...
What is the current status of trial NCT04430634?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-11-01. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT04430634?
The interventions under investigation include: Myblu variant A (OTHER), Myblu variant B (OTHER), Myblu variant C (OTHER), Myblu variant D (OTHER), Myblu variant E (OTHER).
Who is sponsoring clinical trial NCT04430634?
This trial is sponsored by Fontem US, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.